Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have a high-risk primary colorectal cancer (a new cancer in the colon or rectum that has not been treated before).
- People whose CT scan shows no signs of cancer that has spread to the liver.
- People who would be able to receive treatment if cancer in the liver were to be found.
- People who have given written consent to take part in the study.
- People aged 16 years or older.
Who may not be able to join:
- People who have had a previous colorectal cancer (cancer of the colon or rectum) in the past.
- People whose cancer has already spread to other parts of the body.
- People who have a second, separate cancer at the same time.
- People for whom MRI scanning is not safe or suitable (for example, due to certain metal implants or other medical reasons).
- People who have a specific type of lower rectal tumour at a certain stage, without particular features that indicate higher risk (confirm with trial site for full details on this criterion).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Gina Brown, Imperial College London
Phone: +44 (0) 7749 655 817
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Liver metastases found on the additional DW-MRI scans will be discussed at MDT and treated according to local site policy.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.